Calculate the triglyceride-to-HDL cholesterol ratio and use it as a rough lipid-pattern marker alongside the rest of the lipid panel.
The Triglyceride/HDL Ratio Calculator divides triglycerides by HDL cholesterol to produce a simple lipid ratio. The result is sometimes used as a rough pattern marker because higher triglycerides and lower HDL often travel together in insulin resistance and atherogenic dyslipidemia.
The ratio can be useful as context, but it is still only one screening clue. It does not directly measure insulin resistance, LDL particle size, or cardiovascular risk on its own.
Use this page to calculate the ratio quickly, place it into broad descriptive bands, and compare it with the rest of the lipid panel rather than treating the ratio as a stand-alone diagnosis.
The ratio is useful because it is easy to calculate from a standard lipid panel and can highlight a lipid pattern that deserves more review. It is best treated as a quick screening clue rather than as a substitute for formal insulin-resistance testing or full cardiovascular risk assessment.
TG/HDL Ratio = Triglycerides (mg/dL) ÷ HDL Cholesterol (mg/dL) Descriptive Bands Used on This Page: • Lower ratio: < 1.0 • Favorable: 1.0–2.0 • Intermediate: 2.0–3.0 • Higher ratio pattern: 3.0–5.0 • Very high ratio pattern: > 5.0 Note: For mmol/L, divide the mg/dL ratio by 2.3 (or use TG in mmol/L ÷ HDL in mmol/L). These bands are rough context only, not universal diagnostic cutoffs.
Result: TG/HDL Ratio = 3.0 — Higher ratio pattern
TG/HDL = 150 ÷ 50 = 3.0. On this page that lands at the threshold where the lipid pattern deserves a closer metabolic review. The ratio by itself does not prove insulin resistance or specify treatment.
A higher TG/HDL ratio can point toward a less favorable metabolic or lipid pattern, especially when triglycerides are high and HDL is low at the same time. That makes it useful as a quick screening number.
The ratio does not directly measure insulin resistance, LDL particle size, or cardiovascular risk. Those questions still depend on the rest of the lipid panel, glucose markers, blood pressure, anthropometrics, and the broader clinical context.
Use the ratio as one more way to summarize the lipid panel and to follow direction over time. It is most useful when the number is interpreted alongside the rest of the metabolic picture rather than on its own.
Last updated:
This page divides triglycerides by HDL cholesterol to produce the TG/HDL ratio, then places the result into broad descriptive bands used on the page. Those bands are meant to summarize the lipid pattern only; they are not universal diagnostic cutoffs for insulin resistance, metabolic syndrome, or cardiovascular disease.
The result is best treated as a rough metabolic-context clue. A higher TG/HDL ratio has been associated with insulin-resistance and atherogenic-dyslipidemia patterns in observational studies, but it does not directly measure insulin resistance, LDL particle size, or ASCVD risk and should not replace the rest of the lipid panel or broader metabolic evaluation.
Below 2.0 is often treated as a more favorable pattern and above 3.0 as a less favorable one when values are in mg/dL. These bands are rough interpretation guides taken from observational work, not universal diagnostic cutoffs.
Insulin resistance often raises triglycerides and lowers HDL at the same time, which is why the ratio can be informative in some cohorts. It is still only an indirect marker and should not be treated as a direct substitute for formal insulin-resistance measurement.
The TG/HDL ratio is most validated in White and Hispanic populations. In African Americans, triglyceride levels tend to be lower for a given level of insulin resistance due to differences in lipoprotein lipase activity. Different thresholds may apply, and this should be discussed with your doctor.
A higher ratio is often associated with a more atherogenic lipid pattern, including a greater likelihood of smaller LDL particles, but the ratio does not directly measure LDL particle size.
The ratio can change with both medication and lifestyle, but treatment decisions should come from the full lipid picture, triglyceride severity, diabetes status, pancreatitis risk, and clinician guidance rather than the ratio alone.
The ratio reflects two of the lipid features that often travel with metabolic syndrome, so it can work as a quick screening clue. It is still not a substitute for assessing the full metabolic-syndrome criteria directly.